Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TACT
TACT logo

TACT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy TransAct Technologies Inc (TACT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.260
1 Day change
-4.68%
52 Week Range
5.700
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

TransAct Technologies Inc (TACT) is not a strong buy at the moment for a beginner investor with a long-term strategy. The financial performance shows declining net income and EPS, while the technical indicators and trading signals do not suggest a clear entry point. Additionally, there are no significant positive catalysts or recent news to support a bullish outlook.

Technical Analysis

The MACD is slightly positive at 0.0156 but contracting, RSI is neutral at 48.98, and moving averages are converging, indicating no strong trend. Key support and resistance levels are close to the current price, suggesting limited short-term movement.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
2

Positive Catalysts

  • Revenue increased by 11.94% YoY in Q4 2025, and gross margin improved by 7.65% YoY.

Neutral/Negative Catalysts

  • Net income dropped significantly by -85.79% YoY, and EPS declined by -86.08% YoY. No recent news or significant trading trends from hedge funds, insiders, or Congress.

Financial Performance

In Q4 2025, revenue increased to $11.45M (+11.94% YoY), but net income dropped to -$1.13M (-85.79% YoY), and EPS fell to -0.11 (-86.08% YoY). Gross margin improved to 47.57% (+7.65% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst rating or price target changes available.

Wall Street analysts forecast TACT stock price to rise
1 Analyst Rating
Wall Street analysts forecast TACT stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.420
sliders
Low
5
Averages
5
High
5
Current: 3.420
sliders
Low
5
Averages
5
High
5
Roth Capital
Jeff Martin
Buy
downgrade
$6 -> $5
AI Analysis
2025-05-14
Reason
Roth Capital
Jeff Martin
Price Target
$6 -> $5
AI Analysis
2025-05-14
downgrade
Buy
Reason
Roth Capital analyst Jeff Martin lowered the firm's price target on TransAct Technologies to $5 from $6 and keeps a Buy rating on the shares. The firm notes that its prior thesis was based, in part, on a positive outcome from the strategic business review, which has now been suspended. FST and Casino & Gaming segments are performing well while the outlook for TransAct in 2025 remains breakeven to modestly negative on an adjusted EBITDA basis, the analyst tells investors in a research note.

People Also Watch